These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9099151)

  • 21. Calcium restriction, thiazide, citrate, and allopurinol in calcium oxalate nephrolithiasis.
    Coe FL
    Acta Urol Belg; 1994 Jun; 62(2):25-9. PubMed ID: 8037000
    [No Abstract]   [Full Text] [Related]  

  • 22. Potassium-sodium citrate prevents the development of renal microcalculi into symptomatic stones in calcium stone-forming patients.
    Unno R; Taguchi K; Okada A; Ando R; Hamamoto S; Kubota Y; Zuo L; Tozawa K; Kohri K; Yasui T
    Int J Urol; 2017 Jan; 24(1):75-81. PubMed ID: 27747937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 24-Hour Urinary Chemistries and Kidney Stone Risk.
    Ferraro PM; Taylor EN; Curhan GC
    Am J Kidney Dis; 2024 Aug; 84(2):164-169. PubMed ID: 38583757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kidney stone disease: evaluation and medical management.
    Derrick FC; Carter WC
    Postgrad Med; 1979 Oct; 66(4):115-9, 122-5. PubMed ID: 482169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of thiazide therapy in the prophylaxis of calcium lithiasis].
    Fernández Rodríguez A; Arrabal Martín M; García Ruiz MJ; De Haro Muñoz T; Zuluaga Gómez A
    Arch Esp Urol; 2001 Nov; 54(9):1047-54. PubMed ID: 11789362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is selective therapy of recurrent nephrolithiasis possible?
    Pak CY; Peters P; Hurt G; Kadesky M; Fine M; Reisman D; Splann F; Caramela C; Freeman A; Britton F; Sakhaee K; Breslau NA
    Am J Med; 1981 Oct; 71(4):615-22. PubMed ID: 7282750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical and dietary therapy for kidney stone prevention.
    Gul Z; Monga M
    Korean J Urol; 2014 Dec; 55(12):775-9. PubMed ID: 25512810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uric acid and calcium oxalate nephrolithiasis.
    Coe FL
    Kidney Int; 1983 Sep; 24(3):392-403. PubMed ID: 6645213
    [No Abstract]   [Full Text] [Related]  

  • 30. Nephrolithiasis: recent advances in therapy.
    Erwin DT
    South Med J; 1976 Jul; 69(7):935-7. PubMed ID: 941065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissolution of radiolucent renal stones by oral alkalinization with potassium citrate/potassium bicarbonate.
    Trinchieri A; Esposito N; Castelnuovo C
    Arch Ital Urol Androl; 2009 Sep; 81(3):188-91. PubMed ID: 19911683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease.
    Jung H; Andonian S; Assimos D; Averch T; Geavlete P; Kohjimoto Y; Neisius A; Philip J; Saita A; Shah H; Osther PJ
    World J Urol; 2017 Sep; 35(9):1331-1340. PubMed ID: 28160089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chlorthalidone with potassium citrate decreases calcium oxalate stones and increases bone quality in genetic hypercalciuric stone-forming rats.
    Krieger NS; Asplin J; Granja I; Chen L; Spataru D; Wu TT; Grynpas M; Bushinsky DA
    Kidney Int; 2021 May; 99(5):1118-1126. PubMed ID: 33417997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The definition of the mechanism of hypercalciuria is necessary for the treatment of recurrent stone formers.
    Pak CY; Nicar M; Northcutt C
    Contrib Nephrol; 1982; 33():136-51. PubMed ID: 6749417
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nephrolithiasis.
    Khatchadourian J; Pak CY
    Curr Ther Endocrinol Metab; 1994; 5():528-32. PubMed ID: 7704788
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of long-term thiazide therapy on intestinal calcium absorption in patients with recurrent renal calculi.
    Ehrig U; Harrison JE; Wilson DR
    Metabolism; 1974 Feb; 23(2):139-49. PubMed ID: 4810806
    [No Abstract]   [Full Text] [Related]  

  • 38. [3 years' experience in the prevention of recurrent calcic nephrolithiasis].
    Tessitore N; D'Angelo A; Pagano F; Loschiavo C; Fabris A; Lupo A; Tasca A; Morachiello P; Valvo E; Previato G; Chiaramonte S; Sidoti O; Maschio G
    Minerva Nefrol; 1980; 27(2):267-70. PubMed ID: 7219849
    [No Abstract]   [Full Text] [Related]  

  • 39. Uric acid nephrolithiasis: current concepts and controversies.
    Shekarriz B; Stoller ML
    J Urol; 2002 Oct; 168(4 Pt 1):1307-14. PubMed ID: 12352383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of urine oxalate during long-term thiazide therapy in patients with calcium urolithiasis.
    Cohanim M; Yendt ER
    Invest Urol; 1980 Sep; 18(2):170-3. PubMed ID: 7410033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.